Cargando…

Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study

Background and Objectives: Inflammatory bowel disease (IBD) is a condition characterized by chronic intestinal inflammation. We can identify two major forms: Crohn’s disease (CD) and ulcerative colitis (UC). One of the extraintestinal manifestations of IBD is nonalcoholic fatty liver disease (NAFLD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abenavoli, Ludovico, Spagnuolo, Rocco, Scarlata, Giuseppe Guido Maria, Scarpellini, Emidio, Boccuto, Luigi, Luzza, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10673463/ https://www.ncbi.nlm.nih.gov/pubmed/38003983 http://dx.doi.org/10.3390/medicina59111935

Ejemplares similares

Metabolic-Dysfunction-Associated Fatty Liver Disease and Gut Microbiota: From Fatty Liver to Dysmetabolic Syndrome
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Gut Microbiota and Critically Ill Patients: Immunity and Its Modulation via Probiotics and Immunonutrition
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

COVID-19 and Inflammatory Bowel Disease: Patient Knowledge and Perceptions in a Single Center Survey
por: Spagnuolo, Rocco, et al.
Publicado: (2020)

Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2018)

Liver Damage and Impaired Coagulation in COVID-19 Patients: A Case Series
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Human Genes Involved in the Interaction between Host and Gut Microbiome: Regulation and Pathogenic Mechanisms
por: Boccuto, Luigi, et al.
Publicado: (2023)

Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

Silymarin: An option to treat non-alcoholic fatty liver disease
por: Colica, Carmela, et al.
Publicado: (2017)

The Reality of Patient-Reported Outcomes of Health-Related Quality of Life in an Italian Cohort of Patients with Inflammatory Bowel Disease: Results from a Cross-Sectional Study
por: Larussa, Tiziana, et al.
Publicado: (2020)

Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease
por: Dallio, Marcello, et al.
Publicado: (2019)

Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation
por: Tkach, Sergii, et al.
Publicado: (2022)

The Skin in Celiac Disease Patients: The Other Side of the Coin
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic
por: Scarpellini, Emidio, et al.
Publicado: (2020)

Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
por: Abenavoli, Ludovico, et al.
Publicado: (2023)

Self-Prescribed Dietary Restrictions are Common in Inflammatory Bowel Disease Patients and Are Associated with Low Bone Mineralization
por: Larussa, Tiziana, et al.
Publicado: (2019)

Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

The Legacy of Renato Dulbecco in the Post-Genomic Era
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Fecal Microbiota Transplantation in NAFLD Treatment
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study
por: Abenavoli, Ludovico, et al.
Publicado: (2017)

Mediterranean Diet: The Beneficial Effects of Lycopene in Non-Alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Nutritional Support in Acute Liver Failure
por: Abenavoli, Ludovico, et al.
Publicado: (2022)

Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study
por: Tallarico, Martina, et al.
Publicado: (2022)

Race: How the Post-Genomic Era Has Unmasked a Misconception Promoted by Healthcare
por: Schaare, Donna, et al.
Publicado: (2023)

Gut Microbiota and Obesity: A Role for Probiotics
por: Abenavoli, Ludovico, et al.
Publicado: (2019)

Bone Mineralization in Celiac Disease
por: Larussa, Tiziana, et al.
Publicado: (2012)

Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series
por: Larussa, Tiziana, et al.
Publicado: (2021)

Pancreatic Cancer and the Family Connection: The Role of Advanced Practitioners in Screening and Educating Genetically At-Risk Individuals
por: Lowe, Tracy, et al.
Publicado: (2023)

Effect of Whey Proteins on Malnutrition and Extubating Time of Critically Ill COVID-19 Patients
por: Scarcella, Marialaura, et al.
Publicado: (2022)

Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey
por: Larussa, Tiziana, et al.
Publicado: (2019)

The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer
por: Méndez-Sánchez, Nahum, et al.
Publicado: (2020)

Familial pancreatic cancer: a case study and review of the psychosocial effects of diagnoses on families
por: Lowe, Tracy, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Anxiety and Gastrointestinal Symptoms Related to COVID-19 during Italian Lockdown
por: Abenavoli, Ludovico, et al.
Publicado: (2021)

T.04.10 EFFECT OF WHEY PROTEINS ON MALNUTRITION AND EXTUBATING TIME OF CRITICALLY ILL COVID-19 PATIENTS
por: Fabiano, G., et al.
Publicado: (2022)

From Pre- and Probiotics to Post-Biotics: A Narrative Review †
por: Scarpellini, Emidio, et al.
Publicado: (2021)

Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review
por: Montori, Michele, et al.
Publicado: (2023)

How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
por: Cipri, Selene, et al.
Publicado: (2022)

Body Composition and Non-alcoholic Fatty Liver Disease
por: Abenavoli, Ludovico, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k8q5b6fr22d1timr1m4lqobvj4